Ranitidine hydrochloride and Belching - a phase IV clinical study of FDA data

Summary:

Belching is found among people who take Ranitidine hydrochloride, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ranitidine hydrochloride and have Belching. It is created by eHealthMe based on reports of 66,984 people who have side effects when taking Ranitidine hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

66,984 people reported to have side effects when taking Ranitidine hydrochloride.
Among them, 54 people (0.08%) have Belching.


What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 67,576 Ranitidine hydrochloride users for its effectiveness, alternative drugs and more.

What is Belching?

Belching (release of gas from the digestive tract) is found to be associated with 2,013 drugs and 1,455 conditions by eHealthMe.

Number of Ranitidine hydrochloride and Belching reports submitted per year:

Could Ranitidine hydrochloride cause Belching?

Time on Ranitidine hydrochloride when people have Belching *:

  • < 1 month: 83.33 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Belching when taking Ranitidine hydrochloride *:

  • female: 58 %
  • male: 42 %

Age of people who have Belching when taking Ranitidine hydrochloride *:

  • 0-1: 3.33 %
  • 2-9: 0.0 %
  • 10-19: 3.33 %
  • 20-29: 3.33 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 40.0 %
  • 60+: 50.0 %

Common drugs people take besides Ranitidine hydrochloride *:

  1. Cosentyx: 8 people, 14.81%
  2. Ranitidine: 3 people, 5.56%
  3. Esomeprazole Magnesium: 3 people, 5.56%
  4. Tamsulosin: 2 people, 3.70%
  5. Paracetamol: 2 people, 3.70%
  6. Lialda: 2 people, 3.70%
  7. Xgeva: 2 people, 3.70%
  8. Tylenol: 2 people, 3.70%
  9. Gaviscon: 1 person, 1.85%
  10. Flexeril: 1 person, 1.85%

Common side effects people have besides Belching *:

  1. Indigestion: 20 people, 37.04%
  2. Abdominal Distension: 19 people, 35.19%
  3. Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 14 people, 25.93%
  4. Vitamin B12 Deficiency: 14 people, 25.93%
  5. Flatulence (flatus expelled through the anus): 14 people, 25.93%
  6. Oropharyngeal Discomfort (pain or irritation of oropharynx): 14 people, 25.93%
  7. Neck Pain: 14 people, 25.93%
  8. Regurgitation (expulsion of material): 14 people, 25.93%
  9. Nausea (feeling of having an urge to vomit): 11 people, 20.37%
  10. Taste - Impaired: 11 people, 20.37%

Common conditions people have *:

  1. Indigestion: 15 people, 27.78%
  2. Oesophagitis (inflammation of oesophagus): 13 people, 24.07%
  3. Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 11 people, 20.37%
  4. Ankylosing Spondylitis (type of arthritis affecting the spine): 8 people, 14.81%
  5. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 6 people, 11.11%
  6. High Blood Cholesterol: 4 people, 7.41%
  7. High Blood Pressure: 2 people, 3.70%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 3.70%
  9. Pain: 1 person, 1.85%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 1.85%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and have Belching?

Check whether Belching is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Belching and when was it recovered:

Expand to all the drugs that have ingredients of ranitidine hydrochloride:

Alternative drugs to, pros and cons of Ranitidine hydrochloride:

Common Ranitidine hydrochloride side effects:

Browse all side effects of Ranitidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Belching treatments and more:

COVID vaccines that are related to Belching:

Common drugs associated with Belching:

All the drugs that are associated with Belching:

Common conditions associated with Belching:

All the conditions that are associated with Belching:

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Ranitidine hydrochloride) and Ranitidine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: